Loading
Latest filing published 20 May 2021 for Xenon Pharmaceuticals Inc., €6,512. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Only one filing by Michael M. Tarnow is known so far (20 May 2021): an option exercise, €6,512, in Xenon Pharmaceuticals Inc. That is too little to draw conclusions. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration